Olema Pharmaceuticals
OLMA
OLMA
200 hedge funds and large institutions have $2.27B invested in Olema Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 87 funds opening new positions, 55 increasing their positions, 39 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
59% more funds holding
Funds holding: 126 → 200 (+74)
41% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 39
32.66% more ownership
Funds ownership: 99.49% → 132.15% (+33%)
Holders
200
Holding in Top 10
11
Calls
$30.8M
Puts
$17.5M
Top Buyers
| 1 | +$88.9M | |
| 2 | +$58.7M | |
| 3 | +$55.6M | |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$48.9M |
| 5 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$46.3M |
Top Sellers
| 1 | -$34M | |
| 2 | -$20.2M | |
| 3 | -$16.8M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$16M |
| 5 |
Morgan Stanley
New York
|
-$15.8M |
